source
- ctDNA monitoring guides immunotherapy decisions in metastatic urothelial cancerExperts discussed how circulating tumor DNA (ctDNA) testing is being used to follow patients with metastatic urothelial carcinoma and to help shape immunotherapy choices. They noted that a rapid d…
- Specialized logistics critical for delivering next-generation cell and gene therapiesThe article explains that personalized medicines such as cell and gene therapies are transforming treatment for rare diseases and cancers. Unlike conventional drugs, these therapies are often made…